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Mcmbcrs of the Ras superfamily orsmall GTP-binding prolcins. y-subunits of hclcrotrimcric G proteins and nuclear lamin Bare subjccl IO a series 
01’poit-~ranslationnl modificalions lhal produce prcnylcystcinc mcthylcslcr groups al their carboxyl termini. The 0lioclhcr-linked polyisoprcnoid 
substitucm can bc cithcr farncsyl (C,,) or gcranylgcranyl (C:,,). Small molcculc prcnylcysleinc dcrivalivcs with cilhcr Ihe CIs or C:,, modification. 
such as N-acc~yl-S-trtrtt.s.f~rtrr.r -farncsyl-L-cyslcinc (AFC), S-rrotr.s.twtts- farncsylthiopropionalc (FTP), as well as lhc corresponding gcranylgcranyl 
derivaliws (AGGC and GGTP) arc subslralcs for the carboxy mclhyl!ransfcrasc. Swc/trttwttt~cc’.r cewbicrc s/c/J mulanls that lack RAS and 
a-faclor carbosyl mcthyltransfcrasc aclivhy arc also unable LO mclhylarc farncsyl and gcranylgcranylcyslcinc derivatives. hlorcovcr. C,,,-substitured 
cysbzinc analogs dircclly cornpctc for carbosyl mclhylalion with lhc C,,-subsiilubxl cyslcinc analogs and vice versa. Finally. AGGC is cvcn more 
cflix~ivc 1lx111 AFC as an inhibhor or Ras carbosyl mcthylzlion, dcsphc lhc I-XI IIWI Ras is mcthylatcd al a fxncsylcyslcinc rather than a 
gcranylgcranylcystcinc rciiduc. 
Prowin carboxyl mclhylalion; GTP-binding prolcin: Transrorming prowin; Mcmbranc allachmcnl: Prcnglcyslcinc 
I. INTRODUCTION 
A variety of important regulatory proteins in euka- 
ryotic cells are originally translated with a cysteine 4 
amino acids from the C-terminus [I]. Because the 2 
amino acids that follow the cysteine in these proteins are 
generally aliphatic, this structural motif has previously 
been referred to as a “CAAX tail”. where C represents 
a cysteinc, A is an aliphatic residue and X is Ihe C- 
terminal amino acid [2]. In both yeast and mammalian 
cells, 2 distinct proteins prenyltransferase activities have 
been identified that modify CAAX-tail proteins. One 
catalyzes the transfer of the C.,,, polyisoprenoid, gera- 
nylgeranyl, from geranylgeranyl pyrophosphatc lo the 
CAAX-tail cysteine [3,4]. The other catalyzes the cor- 
responding reaction with the CIs polyisoprenoid, farne- 
syl [WI. Because of the differential specificities of the 
prcnyliraiisfeiases [3,10], COAX-tai! proteins !hal end 
in a methionine or serine such as nuclear lamin B [I I], 
Ras [l,l2-151 and the y-subunit of transducin [!6] are 
modified with the Cl5 substitucnt; while proteins with 
A06twi~tri~trr.s: AFC, N-acclyl-S-rrrttrs,/rcttt~-~rncsyl-L-c~slcinc; FTA, 
S-tI.~ttt.~,/r[ttt.~-~drncsyllhioacclic acid; FTP. S-rrutu.rrrrtt.~-Trnc- 
syl-3.thiopropionic acid; AGGC, X-acclyl-S-all-rrwwgcranylgcranyl- 
L-cystcinc; GGTA, S-all-wowgcranylgcranylthioacclic acid; GGTP, 
S-all-rtwtrs-gcranylgcranyl-3-thiopropionic acid; AGC. Wacclyl-b 
rrws-gcranyl-L-cyslcine; AdoMcl, S-adcnosyl-L-mcIhioninc; DTT. 
dithiolhrchol. 
Currespotrr/~vrcr uddrcss: J, Slack, Dcp~. of Molecular Biology, Prince- 
ton Univcrshy, Princeton, NJ 08544, USA. 
CAAX tails that end in a leucine, such as G25K [l7], 
RaplA [l4], RaplB [I81 and Q’s from neural tissue 
[19,20] are modified by the C?,, group. The initial proccs- 
sing event, addition of either the Cl5 or CIu isoprenoid, 
is followed by proteolytic cleavage of the 3 carboxyl- 
terminal amino acids with subsequent methylalion of 
the exposed prenylcystcine carboxylate [12,21]. 
The pathways that result in different prenyl substi- 
tuenls could provide a means for differential regulation 
of individual proteins through interaction with target 
proteins that recognize the C-termini. such as mem- 
brane receptors, methyltransferases and methylester- 
ases [22]. To examine the role of the C-termini in target 
recognition. we have synthesized a variety of small mol- 
eculc analogs. 
Previously, we have reported that the carboxyl mc- 
thyhransferase activities that modify C,,-substituted 
cystcines at the C-termini of pro!eins such as nuc!ear 
lamin B, Ras and the y-subunit of transducin. also ca- 
talyze the carboxyl methylation of small molecular 
weight C,s-substituted cysteinc analogs such as N- 
acetyl-S-farnesylcysteine, AFC [22,23]. AFC methyl- 
transferase activities are ubiquitous to all eukaryotic 
cell types [22,23]. Succlrurw~i~c~s cerevisiue srcl4 
mutants that are deficient in RAS and a-factor methyl- 
transferase activity [24,25] also lack the ability to meth- 
ylatc AFC [22]. Moreover, AFC inhibits the methyla- 
tion of CAAX-tail proteins [22,26,27]. 
Here we address the specificity and characteristics of 
the methyltransferase activities that modify C-terminal 
Cl0 substituted cysteines. Our results indicate that the 
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STEl4 activity in yeast and a single activity in mamma- 
lian cells can catalyze the caboxyl methylation of both 
C,,-substituted analogs, such as AFC and C,,+ubstit.ut- 
cd analogs, such as h’-acetyl-S-all-rraru-geranylgeranyl- 
cysteine (AGGC). This raises the possibility that the 
carboxyl methylation of both classes of CAAX-tailed 
proteins may be catalyzed by the same inethyltransfe- 
rase. 
TFA in acctonitrilc as elution bukrs. Appropriate fractions were 
pooled, dried, then charactcrizcd by NMR and mass spectroscopy. 
2. MATERIALS AND METHODS 
2.3. Itr rirro recorrsrirrtrioti ofp2ih’i.rJ”.‘n post rrarrslnriotral processitrg 
.~y.rrerir 
Recombinant human p2l Ki.‘c”zll was exprcsscd in E.scheric/riu coli 
str;lin BL2l[DE](pLysS) transrormcd with pT7K-Ras-Gly. The 
p2 I K:.rdd” was rccovcred from inclusion ‘sodies by low speed ccntriru- 
gation of sonicated cell extracts. The pellet fraction was dissolved in 
G M guanidine-HCI then dialyzed against 100 mM Tris-HCI, 100 mM 
NaCI, 5 mM MgX, I mbl DTT and 5OpM GTP. After gel filtration 
(7.5 x 300 mm, Ultropac culumn TSK G2000SW. LKB, Bromma, 
Swrdcn), p21 Ki~r:w2l% was judged to be greater than 90% pure by SDS- 
PAGE. 
Except as noted. rcagcnts wcrc purchased from Aldrich Chemical 
Co. (Milwaukee). iV-Acctyl-L-cystcine and phcnylmcthylsulfonyl 
fluoride were purchased from Sigma Chemical Co. (St. Louis). All- 
/rcr,rs-geranylgeraniol wa.j . r? kind gift from R. Coatcs or from Kuraray 
Co. (Tokyo). S-Adenosyl-L-mcthioninc was purchased from Boch- 
ringer Mannheim (Indianapolis). S-Adcnosyl-[“H-methyl]L-nie- 
thioninc and VH] farnesylpyrophosphate were purchased from Du- 
Pont-NEN (Boston). Unlabeled farnesylpyrophosphatc was a kind 
gift from J. Backer. HPLC grade acctonitrilc was purchased from 
Fisher Scicntilic (Pittsburgh). 
Partially purified Tarnesyltransrerase rrom rat brain was prepared 
by Slono Q ion exchange chromatography of’ rat brain cytosol [5]. 
Unmodified p2 I Ki.n”z” was farncsylatcd by incubation in the presence 
of this enzyme plus fdrncsylpyrophosphale. The farncsylatcd 
p2 I Ki~nr.-?ll was further processed by addition oT rat brain membranes 
that cleave the 3 amino acids alier the ~di%csyhWd cystcinc. In the 
prcscnce of [‘H]AdoMet, the membranes also catalyze [‘Hlmcthyla- 
tion or the resultant rarnesylcystcinc n-carboxyl group. 
2.2. S-PrL’tl~I-Cut)ipuIItIfI.y 3. RESULTS 
AFC. FTA, FTP, AGGC. GGTA and GGTP and their corrcspond- 
ing methyl esters wcr? prepared through incubation of cithcr 
rrrrln,rr~,ls-farncsyl bromide or iill-rrltrls-_reranylacranyI bromide with 
cystcinc. mcrcaptoacctic acid or 3-mccaptopropionic acid or methyl 
ester in a manner analogous to our previously reported method for the 
synthesis of AFC and AFC methyl ester [23]. All-rrrrfu-geranylgeranyl 
bromide was prepared from all-r~rrrrs-gcranylgcraniol by an adapta- 
tion of a previously reported method [!8]. All products were puriticd 
by reverse-phase HPLC over a semi-preparative C, column (20 x 250 
mm, I20 A, I5 p spherical particle size. A-243-15, YMC. Morris 
Plains. NJ) with 0.1% trifluoroacctic acid (TFA) in water and 0.1% 
3. I, Pret~~~lcysteirle szetl~~itra~tsfe~ase activifics itf rat 
tissues 
We have previously demonstrated that membrane 
fractions from eukaryotes catalyze the carboxyl meth- 
ylation of AFC [22,23]. The corresponding geranylgera- 
nyl derivative, AGGC, is also methylated by eukaryotic 
membrane fractions. In both rat brains and liver, simi- 
lar subcellular distributions of AFC and AGGC meth- 
yltransferase activities were observed (Table I). 
Table I 
Subccllular localization of S-prenylcystcinc mcthyltransfcrase activity 
in rill tissues 
Fraction Initial rate of Inilial rate 0r 
formation oT AFC i”ormatior. of AGGC 
methyl ester methyl cstcr 
(pmol/mgImin) (pmolim@niin) 
Bruit1 
Total 8.4 8.5 
Nuc1earlE.R. I2 I2 
Mitochondrial 6.3 6.5 
Microsomal I8 I6 
Soluble 0.37 0.45 
Liver 
Total 0.58 oXi0 
Nuc1car:E.R. I.0 I.0 
Mitochondrial I .4 I.4 
Microsomal 2.8 2.4 
Soluble 0.02 0.03 
Subcellular Tractions, prepared as previously dcscribcd [20], wcrc incu- 
bated with [‘H]AdoMct (IO,uClhl; 8000cpmlpmol) and AFC (lOO,#vl) 
or AGGC (75 @l) in 50 mM Tris-HCI, I tnM EDTA. I mM DTT. 
pH 7.9, in a total volume of I75 ~1. Alier IO. 20 and 30 mitt, 50 /rl 
aliquots were rcmovcd rrom each reaction mixture and the lcvcls of 
[‘H]AFC mclhyl cstcr or [jH]AGGC methyl cstcr dcturmincd by our 
previously rcportcd hcptanc extraction method [22]. The lcvcl ol’pro- 
kin in Cach incubation mixture was adjusted IO bc 75 pg. 
S-prciiylcystcine mcthyItransl&isc activily in Succ/raro~~~vc~~ ccrcvi- 
she 
Slrilin 
- 
hISI (MATa) 
HG?9-2d (srell ,IfnTa) Membrane 
Soluble 
Subccllular uractions. prepared as previously described [20]. wcrc incu- 
bated with rH]AdoMct (IO ,uM; 8000 cpmlpmol) and AFC ( IOOpuM) 
or AGGC ( IOOpM) in SO mM Tris-HCI, I mM DTT. pH 7.9, in 11 total 
volume or 175~1. Ahcr IO, 20 and 30 min, SO@ aliquots wcrc removed 
from each rcactiott mixture and the lcvcls of[‘H]AFC methyl ester or 
[“tI]AGGC methyl cstcr dctcrmincd by our previously rcporled 
hcptanc extraction method [22]. The level orprotein in each incubation 
mixtures was adjusted to bc 75 ,ug. 
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Table II 
Frdclion Initial rate or Initial rate 01 
formation 0r rormation 0r 
AFC methyl AGGC methyl 
cstcr (pmoll- cstcr (pmol/- 
mglmin) mumin) 
Membrane 
Soluble 
I.1 I.2 
~0.001 ~0.001 
Membrane 
Soluble 
I.2 I.1 
<o.oo I <O.OOl 
<O.OOl c0.001 
cO.OOl co.00 I 
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Elution Time (mix-t) 
Fig. 1. In vitro carboxyl mcthylation of AFC and AGGC in rat brain. 
An 800 x g mcmbranc fraction from rat brain (16 ~8 protein) was 
incubated at 37°C with [‘H]AdoMet (10 PM; 3800 cpm/pmol) and 
AFC or AGGC in 100 mM Tris-HCI, I mM EDTA, I mM DTT, pH 
7.9, in a total volume of 50 ,uI. Formation of [‘li]AFC methyl ester 
and [3H]AGGC methyl ester was dctcrmined in a manner analogous 
lo our previously reported method [22]. Briefly, after 25 min of incu- 
bation, each reaction was vor:exed togcthcr with 250 ~1 of ice-cold 
heptanc. A 200 ,uI aliquot of the hcptanc layer was rcmovcd, dried in 
a vacuum centrifuge (Savant WC-IOOH), rcsuspcndcd in 500~1 accto- 
nitrilc, then subjected to revcrsc-phase HPLC over a Cln column 
(Vydac 20lTP54). The column was elured at I .5 mhmin for 5 min with 
50% solvent B followed by a linear gradient from 508 solvent A lo 
100% solvent B over 50 min. Solvent A was 0.1% (v/v) trifluoroacctic 
acid (TFA) in water and solvent B was 0. I % (v/v) TF.4 in acetonitrile. 
Fractions wcrc coliccted every 30 s. mixed with 5 ml scintillation fluid 
(ICN EcoLite+) and analyzed by liquid scintillation spcctromctry. 
Arrows indicate the clution times of synthetically prcparcd AFC 
methyl ester (A) and AGGC methyl ester (B). (Top trace) 5OpM AFC; 
(ccntcr trace) 50 ,~fvl AGGC; (lower tract) 50 PM AFC + 50 PM 
AGGC. 
3.2. Pret?ylcystebre tltell~ylIrnrtsfer~tse aclivilies in Sac- 
charomyces ccrevisiae 
??lature RAS and J4.4 Ta-t;jpe matip nhwomones . .O r__> 
(n-factor) from S. cerevisiuc each have a C-terminal 
S-farnesylcystcine methyl ester [1,29]. A sref4 mutant 
strain lacks the activity requires to methylate both RAS 
and a-factor [24,25]. This mutant also lacks both AFC 
and AGGC methyltransferasc activity (Table II). The 
STEf4 gene product is membrane-associated [25], as 
are the AFC and AGGC methyltransferase activities 
(Table II). 
3.3. AFC und AGGC cotnprte for carboxyl tnerhyltiot~ 
A reverse-phase HPLC assay was used to determine 
the extent of carboxyl methylation of AFC and AGGC 
(Fig. 1). Incubation of AFC (50 ,uM) with rat brain 
membrane extract resulted in the formation of 11 pmol/ 
mg/min of AFC methyl ester under the conditions de- 
Table Ill 
Kinetics of prcnylcystcinc carboxyl mcthylation 
Subslralc K,W) Ki of FL-A @M) Ki of GGTA 
WW 
AFC 25 3 2 
FTP 20 5 5 
AGGC 1 3 3 
GGTP 5 3 3 
An 800 x g mcmbranc fraction from rat brain (48 BS protein) was 
incubatcdat 37°C with [lH]AdoMct (IOpM; 3800cpmlpmol) together 
with AFC, FTP. ACGC or GGTP (0.9.23 or 90pM for CIs substra- 
tes; 0. 6, 15 or 60 ,uM for Co substrates) and FfA or GGTA (0. 2, 
9, 23 or 45 PM) in 50 mhl Tris-HCI. I mM EDTA, I mM DTT. pH 
7.9, in a total volume of 175pl. Aficr IO. 20 and 30 min. 50~11 aliquots 
were removed from each reaction mixture and the lcvcls of [‘H]mcthyl 
cstcrs of AFC, FTP. AGGC or GGTP dctcrtnincd by our previously 
reported hcptanc extraction method [23]. Initial rates of formation of 
[‘HImethyl ester as a function of inhibitor concentration wcrc dctcr- 
mined at each concentration of subaratc, then plo!tcd as double 
reciprocal ~101s vs. substrate concentration. The apparent K,,,‘s for the 
substrates, as dctcrmincd from the double reciprocal plots, Were then 
plotted as a function of inhibitor concentration. 
scribed in the figure legend. When AGGC (50 PM) was 
incubated with the extract, 11 pmol of AGGC methyl 
ester was also produced. The amount of AFC methyl 
ester formed was reduced by 80% and the amount of 
AGGC methyl ester was reduced by 20% when AFC 
and AGGC were present together in the incubation 
mixture. These results are consistent with a direct com- 
petition of AFC and AGGC for the same methyl- 
transferase activity where AGGC has a higher affinity 
for the enzyme. 
3.4. Kitletics of protylcysreine carboqd metitylution 
A variety of small molecule anaiogs of C-terminal 
S-prcnylcysteine residues were synthesized to assay the 
substrate specificities of the methyltransferase activities. 
Inhibition of AFC methylation is a useful screen for 
compounds that inhibit the C-terminal S-farnesylcyste- 
ine carboxyl methyltransferase activity [23]. By this 
method we found that several of the analogs compete 
with AFC for the S-farnesylcysteine methyltransferase. 
Two of the compounds, FTA and GGTA, were excel- 
lent inhibitors, but were not substrates. This property 
enabled us to use our previously reported heptanc-ex- 
traction method [23] to determine kinetic parameters of 
the carboxyl methylation reaction (Fig. 2). The method 
is based on our observations that when an aqueous 
incubation mixture of [3H]AdoMet, AFC and enzyme 
source is extracted with tz-heptane, any [‘H]AFC methyl 
ester produced is quantitatively transferred into the 
heptane layer, whereas most other [‘HI-containing 
species in the mixture remain in the aqueous layer. This 
method is equally useful for AGGC, FTP end GGTP, 
since their methyl esters arc also quantitatively trans- 
ferred into heptanc. 
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0.0 l/[AFCI (PM) -I 0.2 0.0 l/IAGGCI (PM)-’ 0.2 
0 50 
Fig. 2. Effca of FTA on the rales of formation of AFC mclhyI csler and AGGC mc~hyl cswr. An 800 x g rncmbranc fraction from rat brain (48 
pg protein) was incubated ill 37’C with [“H]AdoMct (10 ,~%l; 3800 cpmlpmoi) wiih AFC (0,9,23 or 90 flhl) or AGGC (0.6. 15 or 60 PM) and 
FTA (0, 3,9, 23 or 45 PM) in 50 m?vl Tris-MCI, 1 mM EDT& 1 mM DTT. pH 7.9, in a lolaI volume of 175@. After 10, 20 and 30 min, 50 ,uI 
aliquots wcrc rcmovcd from each reaclion mixture and the lcvcls of [‘H]AFC methyl ejtcr and I’HJAGCC methyl cswr dcrcrmincd by our previously 
reported hcpcanc exlranion method [22]. (A) lncub:nion of AXI (9pM) with FTA (0,&l, c; 2@1. l ; 9 @I ,“; 23,~M. ~:45,uM.~)(O) Incubation 
of AGGC (6,uM) wi[h FTA (0 PM, 0; 2 ,&I. l ; 9,&~. a; 23 ,uM, A; 45 PM, I). (C) Initial r~cs of formation of AFC methyl cstcr as a function 
of FTA conccntralion wcrc deIcrminatcd at all cosceniraiions of AFC from the slopes of [he lines as shown in (A) for 9 PM AFC, then ploitcd 
as a double reciprocal plot vs. AFC conccmration. (D) The same mclhod described in (C) was cmploycd IO construct a double reciprocal plots 
of AGGC methyl ester formtalion vs. AGGC conccnlralion. (E) The apparcnl &,‘s of AFC (0) and AGGC (a). as dclermincd from lhc double 
reciprocal plois (C) and (D), arc plotted as a fun-lion of FTA concentration. 
Geranylgeranyl analogs, AGGC en GGTP, have a 
3-4 fold lower K,,, than the correspondingl’arnesyl deriv- 
atives, AFC and FTP (Table Ill), The Ki’s of the com- 
pctitive inhibitors, FTA and GGTA, do not vary fat 
different classes of substrates, however (Table Hi). 
These dara are consistent with the conclusion that C,, 
and Czo prenylcysteine d rivatives are substrates of the 
same methyltransferasc. 
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3.5. Itt!tibitiott of Ras cttrboxyl tttdtylutiott itt u rccott- 
stirlrted post-rratrslutiotlul ttiod$icutiot~ system 
We examined the methylation of Ras in a reconstitut- 
ed post-translational modification system. Unmodified 
human recombinant p2 1 Ki-rr’.‘-2n was overproduced in 
Escherichicr coli and purified. In the experiment report- 
ed in Table IV, ~21 Ki-r”rz” was farnesylated, cleaved and 
used as a substrate for the rat brain methyltransferase. 
In the presence of 50 pill AFC or AGGC the meth- 
ylation of p3 1 Kh.a was inhibited as compared to the 
control lane without any added prenylcysteine analog. 
N-Acetyl-S-trn!u-geranylcysteine (AGC), a structurally 
similar compound where the isoprenoid is the C,, ge- 
ranyl group, is not an effective inhibitor. 
4. DISCUSSION 
Several CAAX-tail proteins are post-translationally 
modified to yield mature proteins with either carboxyl- 
terminal S-farnesylcysteine (C,,) or S-geranylcysteine 
(C,,) methyl esters. We have previously identified a eu- 
karyotic carboxyl mcthyltransferase activity that meth- 
ylates proteins that have a Cl5 group, such as Ras, as 
well as small molecule analogs of the C-terminus, such 
as N-acetyl-S-r~crtls, trllr,u-farnesyl-L-cystcine, AFC [Z]. 
Here we show that small molecule analogs of the car- 
boxyl-terminus of proteins with a C,,, group, such as jV- 
Tdbk Iv 
Carboxyl ~clhykilioll of p?l”“““‘” in a rcconstitutcd proccssintJ sys- 
tcm 
Prcnylcystcinc analog Ras mcthylation 36 kDa-protein mcth- 
Added (50 PM) ($6 control)’ ylalion (G control)? 
AGC 97 97 
AFC G8 96 
AGGC 50 94 
Recombinant human pll”“““~” (7 ,Q) was incubated at 37°C with 
partially purified rat brain fiuncsyllransTcrasc (80~~) and Ftrncsylpy 
rophosphatc (I nmol) in 50 mM Tris-HCI, I mM MgCI,, I mM 
MnCL, I mM DTT, pH 7.0. ror I h in a tomI volume of 35 ~1. A 
iir0 000x g rat brain crude niicrosomal fi?iiiiGil (I j/l, lOflg p&in) 
that was isolated in 50 mM Tris-HCI, I mM DTT. oH 7.9 (Tris!DTT 
butTc!r). was added. This was ihc sdurcc oT both’ &arncsylcystcinc 
pcptidasc and S-Ftrncsylcystcinc carboxyl mcthyltransfcrasc activi- 
tics [22]. Alicr a I5 min incubation at 37’C. aliquots (10.5 ~1) Tram 
the reaction mixture wcrc added IO tubes tha; containsd 
[‘H]AdoMct(BO 000 cpmlpmol) and AGC, AFC. AGGC or no inhibi- 
tor in Tris/DTT burrcr. so mat ~hc final volume was I5pl. the AdoMct 
concentration was 0.67 phi and the inhibitor concentration was 50 
PM. AlIcr 25 min at 37% the mcthylation reaction was stopped by 
the addition or4 x protcingcl loading butTcr (5,ul)and hcatingto9S°C 
i’or 5 min. The extracts wcrc separated by SDS-PAGE on an X-cm-long 
12.5% polyacryhimidc gel 1311. The gel was dried and :hc individual 
Ianus wcrc sliced into 3 mm sections. In addition IO Ras, a 36 kDa 
mcthylotcd protein from ml brain is obscrvcd [22]. The cxtcnt of 
protein mcthylation was assayed by tl1c methanol vapor difhtsion 
[I] Stimmcl, J.B., Dcschc~~cs. R.J.. Volkcr. C.,Stock. J. and Clarke. 
S. !!99n! Biochemistry 29, 9651-9659. 
[2] Barbacid. M. (1987) Annu. Rev. Biochcm. 56. 779-827. 
[3] Scdbra. M.C.. Rciss. Y., Casey. P.J.. Brown. MS. and Goldstein, 
J.L. (199 I) Cell 65.429-434. 
[4] Fincgold. A.A.. Johnson, D.I.. Farnsworth, CC.. Gclb. M.H.. 
Judd, S.R.. Glomsct. J.A. and Tamanoi. F. (1991) Proc. Nail. 
Acad. Sci. USA 88. 44484452. 
(51 Rciss. Y.. Goldstein, J.L.. Scabra, M.C.. CdSCy. P.J. and Brown. 
NI.S. (1990) Cell 62. 81-88. 
[6j Mannc. V.. Roberts. D., Tobin, A., O’Rourkc. E.. DcVirgilio. 
M.. Mcycrs, C.. Ahmcd. N.. Kurt. B.. Rcsh. M.. Kung. H.-F. and 
Barbacid. M. (1990) Proc. NatI. Acad. Sui. USA 87.7541-7545. 
[7] Schabcr, M.D., O’Hara, M.B., Garsky, V.M.. Mosscr. SD.. 
Bcrgslrom. J.D.. Moorcs. S.L.. Marshall, MS.. Friedman. P.A.. 
Dixon. R.A.F. and Gibbs. J.B. 11990) J. Biol. Chum. 14701- 
14704. 
proccdurc as dcscribcd previously [32]. [X] Goodman, L.E.. Judd, S.R., Farnswartll, C.C., Powers. S.. Gclb. 
‘Rus mcthylation control, 0.097 pmOl. M.H., Glomsct, J.A. and Tamanoi. F. (1990) Proc. Natl. Acad. 
!36 kDi1 prorcin mcthylation control. 0.084 pmol. Sci. USA 87.9665-9669. 
acetyl-S-all-trutrs-geranylgcranylcystcinc, AGGC, can 
function as substrates of the same activity. The follow- 
ing tines of evidence support this contention: (i) the 
subcellular distribution of the Cl5 and Cl0 methyl- 
transferase activities are identical in yeast, as well as in 
both rat tissues examined; (ii) a disruption in the Suc- 
churotttyces cerevisiue STEl4 gene blocks methylation 
of both CIs and Co substrates; (iii) the Cl5 and C,,, 
analogs mutually compete for carboxyl methylation; 
(iv) inhibitors of the C, methyltransfcrase also inhibit 
the Cl5 methyltransferase with the same Ki’s; and (v) 
both Cl, and C,, analogs specifically inhibit carboxyl 
methylation of prenylcysteine proteins, such as Ras. 
Our results do not preclude the possibility that there 
may be additional prenylcysteine methyltransferase ac- 
tivities that have varying specificities for different poly- 
isoprenoid substituents. Future purification of the 
membrane-associated activities will address this ques- 
tion. Clearly, however, the yeast methyltransferase and 
the major activities from mammalian cells show little 
preference as to whether a C,, or C,, modificrition is’ 
involved. Previous findings with fungal sex facto! refep- 
tors indicate that this may be a general pattern. A syn- 
thetic geranylgeranyl derivative of a Ttwttelki it~cs- 
setmk-u mating factor, Tremcrogen A-IO, has a higher 
affinity for receptor than the corresponding farnesyl 
derivative which is the native product [30]. Perhaps. the 
primary function in rnammalian cells ofthe longer chain 
polyisoprenoid is simply to confer a slightly higher if- 
finity for a common set of targets in the membrane. 
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